Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

1994

Fryer JP, Leventhal JR, Dalmasso AP, Chen S, Simone PA, Jessurun J, et al. Cellular rejection in discordant xenografts when hyperacute rejection is prevented: analysis using adoptive and passive transfer. Transpl Immunol. 1994;2(2):87-93.

Loda M, Fogt F, French FS, Posner M, Cukor B, Aretz HT, et al. Androgen receptor immunohistochemistry on paraffin-embedded tissue. Mod Pathol. 1994;7(3):388-91.

Newell KJ, Witty JP, Rodgers WH, Matrisian LM. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog. 1994;10(4):199-206.

Sanz L, Berra E, Municio MM, Dominguez I, Lozano J, Johansen T, et al. Zeta PKC plays a critical role during stromelysin promoter activation by platelet-derived growth factor through a novel palindromic element. J Biol Chem. 1994;269(13):10044-9.

Fogt F, Vortmeyer AO, Ahn G, De Girolami U, Hunt RB, Daly T, et al. Neural cyst of the ovary with central nervous system microvasculature. Histopathology. 1994;24(5):477-80.

Jacobs JL, Merriam JC, Chadburn A, Garvin J, Housepian E, Hilal SK. Mesenchymal chondrosarcoma of the orbit. Report of three new cases and review of the literature. Cancer. 1994;73(2):399-405.

Chadburn A, Knowles DM. Paraffin-resistant antigens detectable by antibodies L26 and polyclonal CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin's lymphomas. Am J Clin Pathol. 1994;102(3):284-91.

Qin L, Chavin KD, Lin J, Yagita H, Bromberg JS. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J Exp Med. 1994;179(1):341-6.

Falcone DJ, Borth W, McCaffrey TA, Mathew J, McAdam K. Regulation of macrophage receptor-bound plasmin by autoproteolysis. J Biol Chem. 1994;269(51):32660-6.

McCaffrey TA, Falcone DJ, Vicente D, Du B, Consigli S, Borth W. Protection of transforming growth factor-beta 1 activity by heparin and fucoidan. J Cell Physiol. 1994;159(1):51-9.